These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28031364)

  • 21. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
    Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
    J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions.
    Keck ZY; Op De Beeck A; Hadlock KG; Xia J; Li TK; Dubuisson J; Foung SK
    J Virol; 2004 Sep; 78(17):9224-32. PubMed ID: 15308717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.
    Gu J; Hardy J; Boo I; Vietheer P; McCaffrey K; Alhammad Y; Chopra A; Gaudieri S; Poumbourios P; Coulibaly F; Drummer HE
    J Virol; 2018 May; 92(9):. PubMed ID: 29467319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
    Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins.
    Koutsoudakis G; Dragun J; Pérez-Del-Pulgar S; Coto-Llerena M; Mensa L; Crespo G; González P; Navasa M; Forns X
    PLoS One; 2012; 7(12):e52651. PubMed ID: 23300734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.
    Owsianka A; Clayton RF; Loomis-Price LD; McKeating JA; Patel AH
    J Gen Virol; 2001 Aug; 82(Pt 8):1877-1883. PubMed ID: 11457993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
    Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
    Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
    Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
    J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential interaction strategies of hepatitis c virus genotypes during entry - An in silico investigation of envelope glycoprotein E2 - CD81 interaction.
    Bhattacharjee C; Nandy SK; Das P; Mukhopadhyay A
    Infect Genet Evol; 2019 Apr; 69():48-60. PubMed ID: 30639544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
    Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    Das S; Mullick R; Kumar A; Tandon H; Bose M; Gouthamchandra K; Chandra M; Ravishankar B; Khaja MN; Srinivasan N; Das S; Melkote Subbarao S; Karande AA
    J Gen Virol; 2017 May; 98(5):962-976. PubMed ID: 28221101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization.
    Falkowska E; Kajumo F; Garcia E; Reinus J; Dragic T
    J Virol; 2007 Aug; 81(15):8072-9. PubMed ID: 17507469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus E2 envelope glycoprotein core structure.
    Kong L; Giang E; Nieusma T; Kadam RU; Cogburn KE; Hua Y; Dai X; Stanfield RL; Burton DR; Ward AB; Wilson IA; Law M
    Science; 2013 Nov; 342(6162):1090-4. PubMed ID: 24288331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural insights into hepatitis C virus receptor binding and entry.
    Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
    Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response.
    Vijayamahantesh V; Patra T; Meyer K; Alameh MG; Reagan EK; Weissman D; Ray R
    J Virol; 2022 Jun; 96(12):e0052322. PubMed ID: 35612312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.
    Meola A; Tarr AW; England P; Meredith LW; McClure CP; Foung SK; McKeating JA; Ball JK; Rey FA; Krey T
    J Virol; 2015 Feb; 89(4):2170-81. PubMed ID: 25473061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice.
    Krapchev VB; Rychłowska M; Chmielewska A; Zimmer K; Patel AH; Bieńkowska-Szewczyk K
    Virology; 2018 Jun; 519():33-41. PubMed ID: 29631174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.